BE2021C560I2 - - Google Patents

Info

Publication number
BE2021C560I2
BE2021C560I2 BE2021C560C BE2021C560C BE2021C560I2 BE 2021C560 I2 BE2021C560 I2 BE 2021C560I2 BE 2021C560 C BE2021C560 C BE 2021C560C BE 2021C560 C BE2021C560 C BE 2021C560C BE 2021C560 I2 BE2021C560 I2 BE 2021C560I2
Authority
BE
Belgium
Application number
BE2021C560C
Other languages
Dutch (nl)
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Publication of BE2021C560I2 publication Critical patent/BE2021C560I2/nl

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BE2021C560C 2005-06-27 2021-12-20 BE2021C560I2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition

Publications (1)

Publication Number Publication Date
BE2021C560I2 true BE2021C560I2 (enExample) 2026-02-02

Family

ID=34856207

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2021C560C BE2021C560I2 (enExample) 2005-06-27 2021-12-20

Country Status (8)

Country Link
CN (4) CN101208103B (enExample)
BE (1) BE2021C560I2 (enExample)
ES (1) ES2367918T5 (enExample)
FR (1) FR12C0060I2 (enExample)
GB (1) GB0513069D0 (enExample)
NO (2) NO2021022I1 (enExample)
UA (1) UA97233C2 (enExample)
ZA (3) ZA200710853B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2809349T (pt) * 2012-01-30 2019-02-01 Serum Institute Of India Pvt Ltd Composição imunogénica
HUE049531T2 (hu) * 2012-08-16 2020-10-28 Pfizer Glikokonjugációs eljárások és kompozíciók
HUE066007T2 (hu) * 2016-09-02 2024-07-28 Sanofi Pasteur Inc Neisseria meningitidis oltóanyag
EP3799883A1 (en) * 2016-11-25 2021-04-07 GlaxoSmithKline Biologicals S.A. Nomv-antigen conjugated compounds and use thereof
CN109879967A (zh) * 2017-12-15 2019-06-14 苏州和锐生物科技有限公司 一种乙酰氨基葡萄糖偶联物的制备方法及应用
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
JP2023503086A (ja) * 2019-11-22 2023-01-26 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 細菌サッカリド複合糖質ワクチンの用法及び用量
CN115819616B (zh) * 2021-07-28 2025-04-11 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用
CN115721709A (zh) * 2021-08-27 2023-03-03 康希诺生物股份公司 一种肺炎球菌结合疫苗制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180815A (en) * 1988-04-13 1993-01-19 Fuji Photo Film Co., Ltd. Modified protein for carrying hapten
BR122012003821B8 (pt) * 2000-06-29 2021-05-25 Glaxosmithkline Biologicals Sa composição imunogênica multivalente, uso da mesma, e, processo para produzir a composição imunogênica
WO2002080964A1 (en) * 2001-04-06 2002-10-17 Institut Pasteur Conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of vibrio cholerae 0139 bound to tetanus toxoid
GB0115176D0 (en) * 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
CN1401328A (zh) * 2002-10-18 2003-03-12 北京绿竹生物技术有限责任公司 流行性脑脊髓膜炎多糖-蛋白结合疫苗
EP2172213B1 (en) * 2003-01-30 2013-04-03 Novartis AG Injectable vaccines against multiple meningococcal serogroups

Also Published As

Publication number Publication date
ZA200711074B (en) 2009-07-29
CN101208101A (zh) 2008-06-25
ES2367918T3 (es) 2011-11-10
FR12C0060I1 (enExample) 2012-12-14
GB0513069D0 (en) 2005-08-03
CN101208101B (zh) 2013-01-02
CN101247827B (zh) 2013-07-17
NO2021022I1 (no) 2021-05-25
FR12C0060I2 (fr) 2017-01-06
UA97233C2 (uk) 2012-01-25
CN101222935A (zh) 2008-07-16
CN101208103B (zh) 2013-04-24
CN101208103A (zh) 2008-06-25
CN101222935B (zh) 2015-07-29
NO2025018I1 (no) 2025-04-08
ZA200710909B (en) 2009-04-29
ZA200710853B (en) 2009-04-29
CN101247827A (zh) 2008-08-20
ES2367918T5 (es) 2014-11-21

Similar Documents

Publication Publication Date Title
BE2025C533I2 (enExample)
BE2023C529I2 (enExample)
BE2021C557I2 (enExample)
BE2021C531I2 (enExample)
BE2021C524I2 (enExample)
BE2021C519I2 (enExample)
BE2020C531I2 (enExample)
BE2020C511I2 (enExample)
BE2020C508I2 (enExample)
BE2020C004I2 (enExample)
BE2019C503I2 (enExample)
BE2018C037I2 (enExample)
BE2018C035I2 (enExample)
BE2018C019I2 (enExample)
BE2018C016I2 (enExample)
BE2017C028I2 (enExample)
BE2017C007I2 (enExample)
BE2018C028I2 (enExample)
BE2019C533I2 (enExample)
BE2015C074I2 (enExample)
BE2014C012I2 (enExample)
BE2014C057I2 (enExample)
BE2013C074I2 (enExample)
BE2013C014I2 (enExample)
BE2012C042I2 (enExample)